指南与共识湿疹皮炎与荨麻疹

第五届国际共识会议报告:协调特应性湿疹/皮炎临床试验核心结局指标(HOME倡议)

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
指南 / 共识 · Br J Dermatol · 2018-04-19

本文为HOME倡议第五届会议(HOME V)报告,会议于2017年6月12日至14日在法国南特举行,有81名参与者。会议主要目标是就长期控制核心域的定义及其测量方法达成共识,并确定儿童生活质量核心域测量的未来研究优先领域。共识认为长期控制域应包括体征、症状、生活质量和患者整体评估工具,并同意在评估湿疹长期控制时除症状域记录的瘙痒频率外还应测量瘙痒强度;未推荐儿童生活质量核心域的测量工具,但评估了现有工具的表面效度和可行性。

要点

  • 长期控制核心域应包括体征、症状、生活质量和患者整体评估工具。
  • 评估湿疹长期控制时,除症状域记录的瘙痒频率外,还应测量瘙痒强度。
  • 未推荐儿童生活质量核心域的测量工具,但评估了现有工具的表面效度和可行性。

核心结论

  • 共识认为长期控制域应包括体征、症状、生活质量和患者整体评估工具。
  • 共识认为评估湿疹长期控制时,除症状域记录的瘙痒频率外,还应测量瘙痒强度。
  • 未推荐儿童生活质量核心域的测量工具,但评估了现有工具的表面效度和可行性,并确定了有助于未来推荐工具的工作。

研究设计与样本

  • HOME倡议第五届会议(HOME V)于2017年6月12日至14日在法国南特举行,有81名参与者。
  • 采用主持人引导的全组和小组共识讨论,讨论基于定性研究、系统综述和验证研究的报告。
  • 小组成员分配为预先进行,以确保每组包含来自不同地理区域的不同利益相关者。
  • 采用手持电子投票垫进行匿名全组投票,依据预设的共识规则。

主要发现

  • 共识认为长期控制域应包括体征、症状、生活质量和患者整体评估工具。
  • 共识认为评估湿疹长期控制时,除症状域记录的瘙痒频率外,还应测量瘙痒强度。
  • 未推荐儿童生活质量核心域的测量工具,但评估了现有工具的表面效度和可行性。

关键数值与推荐

  • 长期控制核心域应包括体征、症状、生活质量和患者整体评估工具。
  • 评估湿疹长期控制时,除症状域记录的瘙痒频率外,还应测量瘙痒强度。
  • 未推荐儿童生活质量核心域的测量工具,但评估了现有工具的表面效度和可行性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus over the definition of the core domain of long-term control and how to measure it and (ii) to prioritize future areas of research for the measurement of the core domain of quality of life (QoL) in children. Moderated whole-group and small-group consensus discussions were informed by presentations of qualitative studies, systematic reviews and validation studies. Small-group allocations were performed a priori to ensure that each group included different stakeholders from a variety of geographical regions. Anonymous whole-group voting was carried out using handheld electronic voting pads according to predefined consensus rules. It was agreed by consensus that the long-term control domain should include signs, symptoms, quality of life and a patient global instrument. The group agreed that itch intensity should be measured when assessing long-term control of eczema in addition to the frequency of itch captured by the symptoms domain. There was no recommendation of an instrument for the core outcome domain of quality of life in children, but existing instruments were assessed for face validity and feasibility, and future work that will facilitate the recommendation of an instrument was agreed upon.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Chalmers JR, Thomas KS, Apfelbacher C, et al. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). Br J Dermatol. 2018. PMID: 29672835. doi:10.1111/bjd.16543

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。